The Buck Institute for Research on Aging has recently been awarded three grants and partnered with the Astera Institute. The two institutions are collaborating on the Rejuvenome Project — a seven-year, $70 million study — focusing on techniques to slow the aging process. The Buck was also granted $14 million from NIH to research cellular senescence and Alzheimer’s disease — a new approach to studying dementia.
“This project is a quintessential example of the Buck’s strength,” says Buck President and CEO Eric Verdin, M.D. A second $12.7 million grant from NIH gives Buck access to SenNet, a Cellular Senescence Network, for a collaborative, extensive national tissue and cell mapping project.